Drug Trial Radar · NCT02466204
Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients
Last checked: Nov 20, 2026Latest source record: Aug 22, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
400
Actual
Start
Jun 1, 2015
Primary completion
Aug 10, 2016
Study completion Aug 15, 2017
Sponsor
- Lead sponsor
- Vietnam National UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Merck Sharp & Dohme LLC; Mỹ Đức Hospital
- First posted
- Jun 9, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 35 years, up to 42 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, randomized, controlled study to explore the efficacy and safety of using either corifollitropin alfa 150 mcg or daily recombinant follicle stimulation hormone (FSH) 300 international unit (IU) for the stimulation treatment of subjects undergoing controlled ovarian stimulation prior to IVF. The study is designed as a non-inferiority trial. The sample size for this trial of 400 subjects, in both groups, being treated for one IVF cycle is based upon the primary endpoint of the number of oocytes retrieved.
Conditions
- Infertility
Interventions
corifollitropin alfaDrug
Drug is injected subcutaneously. Seven days after, 300 IU FSH daily injected subcutaneously, until at least two leading ovarian follicles reach 17mm in diameter.
Follitropin BetaDrug
Drug is injected subcutaneously, daily, until at least two leading ovarian follicles reach 17mm in diameter.
Primary outcomes
What the sponsor says the trial is designed to measure.
- number of oocytesTime frame: 10 minutes after oocyte retrieval completed
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
My Duc Hospital
Ho Chi Minh City, Vietnam
Research Center for Genetics and Reproductive Health
Ho Chi Minh City, Vietnam
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.